Q3 2023 EPS Estimates for The Chemours Company Cut by Analyst (NYSE:CC)
The Chemours Company (NYSE:CC – Free Report) – Investment analysts at Zacks Research decreased their Q3 2023 EPS estimates for Chemours in a research note issued to investors on Tuesday, August 8th. Zacks Research analyst M. Agrawal now expects that the specialty chemicals company will post earnings per share of $0.89 for the quarter, down […]